Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

NCT04548440 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Sintilimab
DRUG: Nab paclitaxel
DRUG: Cisplatin

Sponsor

Sun Yat-Sen University Cancer Center

Collaborators

[object Object]
[object Object]